⌘K
t
Hikma Pharmaceuticals PLC filed a Block Listing Six Monthly Return on 1 October 2025. The return covers the period from 1 April 2025 to 30 September 2025 for its 2018 Management Incentive Plan and 2014 Executive Incentive Plan. During this period, zero ordinary shares of 10 pence were issued under the schemes, leaving a balance of 311,430 unallotted shares.
| Date | 1 Oct 2025 |
| Time | 11:45:49 |
| Category | Capital structure |
| ID | 6481B |
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 1 October 2025
|
Name of applicant: |
Hikma Pharmaceuticals PLC |
|||
|
Name of schemes: |
Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
|||
|
Period of return |
From: |
1 April 2025 |
To: |
30 September 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
311,430 Ordinary Shares of 10 pence |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 Ordinary Shares of 10 pence |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 Ordinary Shares of 10 pence |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
311,430 Ordinary Shares of 10 pence |
|||
|
Name of contact: |
Helen Middlemist |
|
Telephone number of contact: |
+44(0)20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)